New Biomarker to Guide Cancer Immunotherapy
RNA expression of ERV3-2 (for 2 different primers) is signiﬁcantly higher in tumors from responders compared with tumors from non-responders.
Immunotherapy has led to dramatic responses in many cancer types, but only a minority of patients has clinical benefit. In certain cancers, including renal cell carcinoma, no clear correlation...
Inventor(s): Shridar Ganesan, Gyan Bhanot, Anshuman Panda, W. Kimryn Rathmell, Aguirre de Cubas
Keywords(s): Anti-cancer, Biomarkers, Cancer biomarkers
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Diagnostics, Technology Classifications > Therapeutics